Entresto tops mainstay ACE inhibitor in heart failure trialTwo years ago, Novartis launched a big trials programme for its heart failure drug Entresto in the hope Share XEntresto tops mainstay ACE inhibitor in heart failure trialhttps://pharmaphorum.com/news/entresto-tops-mainstay-ace-inhibitor-in-heart-failure-trial/
